Concepedia

Remission Induction Therapy

Remission Induction Therapy is a therapeutic strategy in the management of autoimmune vasculitis and inflammatory diseases that belongs to the class of pharmacotherapeutic interventions and is distinguished by its aim to rapidly suppress disease activity, achieve clinical remission, and prevent irreversible organ damage through intensive, often immunosuppressive, treatment regimens.

2.6K

Publications

193.4K

Citations

16.5K

Authors

3.5K

Institutions

Publications per year

2017–2026

647

Parents

Publications

2.6K

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

, , +15

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text

, , +17

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al. · New England Journal of Medicine · 2013 · 2.7K citations · Full text

, , +14

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation

Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

, , +16

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Brian G. Feagan, William J. Sandborn, Christopher Gasink et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

, , +17

1–5 of 2.6K

Authors

16.5K

  1. DJ
    David Jayne

    University of Cambridge, United Kingdom

    51 publications · 10.1K citations

    36

    h-index

  2. WJ
    William J. Sandborn

    University of California San Diego, United States

    47 publications · 17.1K citations

    33

    h-index

  3. HM
    Hagop M. Kantarjian

    The University of Texas MD Anderson Cancer Center, United States

    40 publications · 5.2K citations

    30

    h-index

  4. EH
    Elihu H. Estey

    The University of Texas MD Anderson Cancer Center, United States

    26 publications · 2K citations

    24

    h-index

  5. PA
    Peter A. Merkel

    University of Pennsylvania, United States

    25 publications · 6.7K citations

    23

    h-index

1–5 of 16.5K

Institutions

3.5K

  1. St. Jude Children's Research Hospital

    Memphis, United States

    41 h-index

    333 publications

    19K citations

  2. Mayo Clinic

    Rochester, United States

    40 h-index

    245 publications

    54.4K citations

  3. Assistance Publique – Hôpitaux de Paris

    Paris, France

    39 h-index

    255 publications

    34.5K citations

  4. Université Paris Cité

    Paris, France

    39 h-index

    282 publications

    54.2K citations

  5. Inserm

    Paris, France

    39 h-index

    247 publications

    40.3K citations

  6. Dana-Farber Cancer Institute

    Boston, United States

    38 h-index

    230 publications

    35K citations

  7. The University of Texas MD Anderson Cancer Center

    Houston, United States

    34 h-index

    396 publications

    28.3K citations

  8. Johns Hopkins University

    Baltimore, United States

    32 h-index

    126 publications

    19.1K citations

1–8 of 3.5K

Venues

  1. Journal of Clinical Oncology

    213 publications · 27.6K citations

    98

    h-index

  2. Cancer

    150 publications · 10.3K citations

    56

    h-index

  3. British Journal of Haematology

    BJH · 118 publications · 6.6K citations

    49

    h-index

  4. PubMed

    Repository · 218 publications · 8.8K citations

    47

    h-index

  5. Blood

    88 publications · 8.9K citations

    45

    h-index

1–5